Quotient has officially opened its state-of-the-art Allan-Robb Campus within the Scottish Enterprise Biocampus just outside of Edinburgh.

Franz Walt, interim chief executive officer of Quotient, said, “Along with research & development and management, the Allan-Robb Campus will house our reagent manufacturing operations and will provide further capacity to supply the reagent requirements for our MosaiQ™ system.”

The construction phase of the GBP 29 million manufacturing facility started in 2016. The Allan-Robb Campus is named after John Allan and Gordon Robb, two senior executives who have been key in building Quotient into a global company from its roots as a unit of the Scottish National Blood Transfusion Service supplying immunohematology reagents to the Scottish NHS. 

The new facility comprises 85,000 square feet of space, compared with its previous 22,000 square feet at a close-by location, and brings together onto one site Quotient’s Edinburgh team that had previously been spread over four locations. 

The new facility now also houses Quotient’s scientific research team working on developing Quotient’s products and accessing new markets. In 2017, the team secured 17 new product licence approvals from the FDA for sale in the USA. In addition, the Allan-Robb Campus will provide laboratory and office space for a team of about 50 scientists working with other group companies on the development of the MosaiQ™ system.